Page last updated: 2024-08-23

transferrin and Nasopharyngeal Carcinoma

transferrin has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Li, G; Li, J; Liu, T; Lu, Z; Wu, X; Zhang, S1

Other Studies

1 other study(ies) available for transferrin and Nasopharyngeal Carcinoma

ArticleYear
Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.
    Drug delivery, 2019, Volume: 26, Issue:1

    Topics: 3T3 Cells; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Glutathione; Graphite; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA, Small Interfering; Transferrin

2019